各种虚拟现实技术对轻度认知障碍的老年人认知功能的比较有效性:系统性审查和网络元分析
Rixin Qin1, Zhong Li1, Kexin Huang2
1School of Nursing, Beihua University, Jilin, China.
Journal of the American Medical Directors Association
|October 18, 2025
概括
半沉浸式虚拟现实 (VR) 在改善轻度认知障碍 (MCI) 的老年人认知方面最有效. 与对照组相比,所有VR类型都显著提高了全球认知能力.
科学领域:
- 老年学和认知神经科学
- 数字健康干预措施 数字健康干预措施
- 虚拟现实应用 虚拟现实应用
背景情况:
- 轻度认知障碍 (MCI) 影响着老年人口的很大一部分,影响认知功能.
- 虚拟现实 (VR) 技术正在成为潜在的认知康复和增强工具.
- 了解不同VR模式的比较有效性对于有针对性的干预至关重要.
研究的目的:
- 系统地比较和排名各种虚拟现实 (VR) 技术在被诊断为轻度认知障碍 (MCI) 的老年人认知功能的有效性.
- 评估VR干预对这一人口群体认知表现的整体影响.
- 为在临床实践中选择最佳VR模式提供基于证据的指导.
主要方法:
- 进行了随机对照试验 (RCT) 的系统审查和网络元分析 (NMA).
- 研究通过对9个主要数据库的全面搜索确定了研究,截至2025年1月.
- 资格标准集中在涉及老年人 (≥60岁) 的RCT,MCI接受VR干预.
主要成果:
- 包含529名参与者的12个RCT被纳入分析.
- 与注意力控制组相比,所有测试的VR干预都显示了全球认知功能的显著改善.
- 半沉浸式VR (87.8%的排名) 和非沉浸式VR (84.2%) 显示出比沉浸式VR (43.6%) 更高的疗效.
结论:
- 半沉浸式VR成为增强MCI老年人的全球认知最有效的模式.
- 这些发现支持各种VR类型的显著认知益处,为干预提供了一个有希望的途径.
- 建议进行进一步的大规模,长期的RCT,以确认这些结果,并为临床实施策略提供信息.
相关概念视频
01:30Cognitive Development During Adulthood
770
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
770
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
185
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
185
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
552
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
552